LIQUIDITY ALERT: Axesstel Inc. Has US$11.8-Mil. Current Deficit
At Dec. 31, 2011, Axesstel, Inc., had a stockholders’ deficit of US$11.6 million and a working capital deficit of US$11.8 million. The Company has a working capital deficit of US$13.1…
At Dec. 31, 2011, Axesstel, Inc., had a stockholders’ deficit of US$11.6 million and a working capital deficit of US$11.8 million. The Company has a working capital deficit of US$13.1…
At December 31, 2011, Derycz Scientific, Inc., had total current assets of $12,191,437 and total current liabilities of $12,232,344, resulting in a working capital deficit of $40,907, according to the…
At December 31, 2011, BioAnalytical Systems, Inc., had total current assets of $9,397,000 and total current liabilities of $16,394,000, resulting in a working capital deficit of $6,997,000, according to the…
Energy Future Holdings Corp.’s working capital deficit was US$311.0 million as of Dec. 31, 2011. The deficit was US$684.0 million as of Dec. 31, 2010.
Available liquidity decreased US$856 million in…
At December 31, 2011, Corning Natural Gas Corporation had total current assets of $6,451,637 and total current liabilities of $13,244,896, resulting in a working capital deficit of $6,793,259, according to…
At Dec. 31, 2011, Gryphon Gold Corporation had negative working capital of US$3,336,648. The Company had positive working capital of US$877,212 at March 31, 2011.
During the nine months ended Dec.…
At December 31, 2011, Bulova Technologies Group, Inc., had total current assets of $1,079,375 and total current liabilities of $15,373,487, resulting in a working capital deficit of $14,294,112, according to…
At December 31, 2011, Zayo Group, LLC, had total current assets of $66,539,000 and total current liabilities of $107,936,000, resulting in a working capital deficit of $41,397,000, according to the…
ONEOK, Inc.’s working capital deficit was US$927.4 million as of Dec. 31, 2011. The deficit was US$771.7 million as of Dec. 31, 2010.
Cash flows from operating activities, before changes in…
At December 31, 2011, iBio, Inc., had total current assets of $1,938,151 and total current liabilities of $4,714,757, resulting in a working capital deficit of $2,776,606, according to the Company’s…